Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/projects/427-geddis-a-prospective-randomised-controlled-phase-iii-trial-of-gemcitabine-and-docetaxel-com-pared-with-doxorubicin-as-first-line-treatment-in-previously-untreated-advanced-unresectable-or-metastatic-soft-tissue-sarcomas/authors